DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Docetaxel
Docetaxel
Combination of Cabazitaxel and Plicamycin Induces Cell Death in Drug Resistant B-Cell Acute Lymphoblastic Leukemia
Consumer Medicine Information
Identification of Inhibitors of Ovarian Cancer Stem-Like Cells by High-Throughput Screening Roman Mezencev, Lijuan Wang and John F Mcdonald*
Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients with Breast Cancer: Estimates from SEER-Medicare Data
Chemotherapy and Polyneuropathies Grisold W, Oberndorfer S Windebank AJ European Association of Neurooncology Magazine 2012; 2 (1) 25-36
Chemotherapy Protocol
Docetaxel and Cyclophosphamide Chemotherapy Guide
CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
TAXOTERE (DOCETAXEL) ) MDL No. 16-2740 PRODUCTS LIABILITY ) LITIGATION ) SECTION: “H” (5) ) This Document Relates To: ) Elizabeth Kahn, 16-17039 )
HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use DOCETAXEL Safely And
Cancer Drug Counselling: a Guide for Pharmacists
Cancer Drug Costs for a Month of Treatment at Initial Food
About Ewing Tumors What Is the Ewing Family of Tumors?
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
TAXOTERE (Docetaxel) Injection Concentrate Is a Clear Yellow to Brownish-Yellow Viscous Solution
Combination Chemotherapy with Docetaxel, Vinorelbine and Estramustine Phosphate in Metastatic Androgen-Resistant Prostate Cancer: a Single Institution Experience
Hoosier Oncology Group Randomized Phase II Study of Docetaxel
Top View
BRAJDC Protocol
Original Article Docetaxel, 5-Fluorouracil, and Leucovorin As
CY 2012 CDER Fast Track Calendar Year Approvals* Data As of 12-31-2012 Total of 20 Approvals
8. Malignant Disease and Immunosuppression
Docetaxel-Fluorouracil-Folinic Acid-Oxaliplatin (FLOT)
Chemotherapy Regimen: TC
HOPA News Volume 10, Issue 1
Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local Or Metastatic Esophageal Cancer
Chemotherapy Protocol HEAD and NECK CANCER CISPLATIN (75)
Mechanisms of Taxane Resistance
Emetogenic Potential of Antineoplastic Agents
Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review
Computationally Predicting Clinical Drug Combination Efficacy With
Breast Pathway Group– TC (Docetaxel / Cyclophosphamide) in Early Breast Cancer
Handling Cytostatic Drugs: Contents
(PDF) Download
TAXOTERE: TAXOTERE Safely and Effectively